Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B N Bouma

Showing results (21-30 of 200) with videos related to

Pageof 20
Sort By:
Blood|November 1, 1983
Immunologic studies of human coagulation factor XI and its complex with high molecular weight kininogenB N Bouma, R A Vlooswijk, J H Griffin
Advances in Experimental Medicine and Biology|January 1, 1983
Immunological studies of human Factor XI and prekallikrein: demonstration of complex formation with high molecular weight kininogenB N Bouma, R A Vlooswijk, J H Griffin
Biochemistry|February 9, 1988
Inhibition of human blood coagulation factor XIa by C-1 inhibitorJ C Meijers, R A Vlooswijk, B N Bouma
Thrombosis and Haemostasis|November 1, 2001
The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysisL O Mosnier, J C Meijers, B N Bouma
Thrombosis and Haemostasis|February 24, 2001
Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulinL O Mosnier, J C Meijers, B N Bouma
The Journal of Biological Chemistry|May 10, 1980
Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikreinD M Kerbiriou, B N Bouma, J H Griffin
The Journal of Laboratory and Clinical Medicine|April 1, 1984
Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitorsF H Derkx, B N Bouma, M A Schalekamp
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1990
The binding site of human C4b-binding protein on complement C4 is localized in the alpha'-chainM Hessing, C van 'T Veer, B N Bouma
Biochemistry|September 8, 1987
Inhibition of human blood coagulation factor Xa by alpha 2-macroglobulinJ C Meijers, P N Tijburg, B N Bouma
The Netherlands Journal of Medicine|January 1, 1973
Control of heparin therapy with an activated partial thromboplastin timeJ W Akkerman, J J Sixma, B N Bouma
Pageof 20

Showing results (21-30 of 200) with videos related to

Sort By:
Pageof 20
Blood|November 1, 1983
Immunologic studies of human coagulation factor XI and its complex with high molecular weight kininogenB N Bouma, R A Vlooswijk, J H Griffin
Advances in Experimental Medicine and Biology|January 1, 1983
Immunological studies of human Factor XI and prekallikrein: demonstration of complex formation with high molecular weight kininogenB N Bouma, R A Vlooswijk, J H Griffin
Biochemistry|February 9, 1988
Inhibition of human blood coagulation factor XIa by C-1 inhibitorJ C Meijers, R A Vlooswijk, B N Bouma
Thrombosis and Haemostasis|November 1, 2001
The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysisL O Mosnier, J C Meijers, B N Bouma
Thrombosis and Haemostasis|February 24, 2001
Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulinL O Mosnier, J C Meijers, B N Bouma
The Journal of Biological Chemistry|May 10, 1980
Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikreinD M Kerbiriou, B N Bouma, J H Griffin
The Journal of Laboratory and Clinical Medicine|April 1, 1984
Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitorsF H Derkx, B N Bouma, M A Schalekamp
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1990
The binding site of human C4b-binding protein on complement C4 is localized in the alpha'-chainM Hessing, C van 'T Veer, B N Bouma
Biochemistry|September 8, 1987
Inhibition of human blood coagulation factor Xa by alpha 2-macroglobulinJ C Meijers, P N Tijburg, B N Bouma
The Netherlands Journal of Medicine|January 1, 1973
Control of heparin therapy with an activated partial thromboplastin timeJ W Akkerman, J J Sixma, B N Bouma
Pageof 20